BackReplimune Group Overview

Replimune Group Short-Term Investments

Track Replimune Group's short-term investments ($10M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Short-Term Investments
$9.97M
↓ 96.74% YoYΔ $-296.00M vs prior year quarter

Peer trimmed avg / median

Loading

Replimune Group Short-Term Investments History

Loading

Replimune Group vs. peers: Short-Term Investments Comparison

Loading

Replimune Group Short-Term Investments Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Replimune Group (REPL) FAQ

As of the most recent data (June 2026), REPL shows a short-term investments of $10M. That compares with $310M in the prior-year period — down 96.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, REPL's short-term investments is now $10M (was $310M) — a 96.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Replimune Group is outperforming or lagging.

Tracking REPL's short-term investments over time shows whether Replimune Group is scaling, shrinking, or reshaping that part of the business. The current reading is $10M That compares with $310M in the prior-year period — down 96.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this short-term investments page, Stockcircle has Replimune Group's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect short-term investments (currently $10M) with ownership activity and broader fundamentals.

Replimune Group's short-term investments is $10M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.